News & updates

EXTERNAL PRESS AND PUBLICATIONS

30.01.2025: Liom Publishes Groundbreaking Calibration-Free Non-Invasive Glucose Monitoring Results in JDST (Newswire):

Liom has now released the results of one of its external clinical studies in the Journal of Diabetes Science and Technology (JDST), marking another major milestone in the validation of its non-invasive glucose monitoring technology through a peer-reviewed publication

04.12.2024: Liom cracks “holy grail” of non-invasive glucose monitoring and secures USD >25m in funding kickstarting its Series A (Newswire):

Liom is thrilled to announce significant technological milestones and a successful kick-off of its Series A

31.07.2024: New brand – Spiden is becoming Liom (LinkedIn):

We are thrilled to announce that Spiden is now becoming Liom – pursuing non-invasive glucose monitoring, seamlessly integrated with health metrics into the ultimate wearable

05.01.2024: New breakthrough in non-invasive glucose monitoring (Newswire):

Liom announces breakthrough in non-invasive glucose monitoring, adds key executive hires and secures $15m in additional funding

04.09.2023: Disrupting the smart wearables industry (Impulse podcast):

Interview with our CEO Leo Grünstein on how Liom got on the path of creating the most advanced wearable capable of continuously and non-invasively measuring multiple biomarkers circulating in our bodies

18.08.2023: Liom will Apple bei Blutzucker-Technik überholen (Handelsblatt):

Das Schweizer Start-up entwickelt einen Handgelenk-Tracker, der den Blutzuckerspiegel ohne Nadelstich misst. Das könnte die Behandlung von Diabetikern einfacher und günstiger machen

29.04.2021: Liom raises CHF 18m (Businesswire):

Swiss-based Longevity-focused Startup Liom Raises $18 Million to Expand Its Light+AI-based Real-time Blood Diagnostics Platform

UPDATES

15.06.2023: ISO 13485:2016 certification:

Liom has been assessed and certified as meeting the requirements of ISO 13485:2016 for the design and development of non-invasive medical devices for measuring biomarkers and drugs in bodily fluids and tissues

11.06.2022: Move into new 1800m2 office & visitor day:

To accomodate our growing team and needs for high-performance infrastructure, Liom has relocated to a new 1800m2 office in Pfäffikon SZ. Marking this significant milestone, we invited partners, investors and other stakeholders to our new facilities